{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:50:41Z","timestamp":1791319841281,"version":"4.3.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jneuroim.2026.579018","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T14:18:13Z","timestamp":1782656293000},"page":"579018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Peripheral redox biomarkers in multiple sclerosis: associations with phenotype, cognition, and fatigue"],"prefix":"10.1016","volume":"419","author":[{"given":"Sanja","family":"Gluscevic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine Rabia","family":"Koc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Klisic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjalf","family":"Ziemssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3\u20134","key":"10.1016\/j.jneuroim.2026.579018_bb0005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.clinbiochem.2006.10.017","article-title":"A novel assay for the evaluation of the prooxidant-antioxidant balance, before and after antioxidant vitamin administration in type 2 diabetic patients","volume":"40","author":"Alamdari","year":"2007","journal-title":"Clin. Biochem."},{"issue":"5","key":"10.1016\/j.jneuroim.2026.579018_bb0010","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00401-012-0953-0","article-title":"Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?","volume":"123","author":"Antel","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"7","key":"10.1016\/j.jneuroim.2026.579018_bb0015","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.drudis.2020.05.001","article-title":"Role of oxidative stress in depression","volume":"25","author":"Bhatt","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.jneuroim.2026.579018_bb0020","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/sleep\/33.8.1061","article-title":"Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment","volume":"33","author":"Braley","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.jneuroim.2026.579018_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.psychres.2016.01.075","article-title":"Evaluation of malondialdehyde, superoxide dismutase and catalase activity and their diagnostic value in drug-na\u00efve, first-episode, non-smoker major depression patients and healthy controls","volume":"238","author":"Camkurt","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jneuroim.2026.579018_bb0030","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.biocel.2016.06.008","article-title":"Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases","volume":"81","author":"Castellazzi","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.579018_bb0035","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1177\/1352458517711568","article-title":"In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis","volume":"24","author":"Choi","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2026.579018_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuro.2013.08.011","article-title":"Paraoxonase-2 (PON2) in brain and its potential role in neuroprotection","volume":"43","author":"Costa","year":"2014","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jneuroim.2026.579018_bb0045","doi-asserted-by":"crossref","DOI":"10.1177\/17562864241306684","article-title":"Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance","volume":"17","author":"Dal-Bianco","year":"2024","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jneuroim.2026.579018_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocn.2024.110990","article-title":"Association of serum levels of inflammation and oxidative stress markers with cognitive outcomes in multiple sclerosis: a systematic review","volume":"132","author":"Daneshvar","year":"2025","journal-title":"J. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579018_bb0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579018_bb0060","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clinbiochem.2003.11.015","article-title":"A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation","volume":"37","author":"Erel","year":"2004","journal-title":"Clin. Biochem."},{"issue":"12","key":"10.1016\/j.jneuroim.2026.579018_bb0065","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.clinbiochem.2005.08.008","article-title":"A new automated colorimetric method for measuring total oxidant status","volume":"38","author":"Erel","year":"2005","journal-title":"Clin. Biochem."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.579018_bb0070","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1191\/1352458505ms1240oa","article-title":"Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity","volume":"11","author":"Ferretti","year":"2005","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579018_bb0075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579018_bb0080","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/brain\/aws012","article-title":"NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury","volume":"135","author":"Fischer","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2026.579018_bb0085","series-title":"Oxidative Stress and Free Radical Damage in Neurology","first-page":"19","article-title":"Why is the nervous system vulnerable to oxidative stress?","author":"Gadoth","year":"2011"},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579018_bb0090","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00415-004-0348-9","article-title":"The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy","volume":"251","author":"Gilgun-Sherki","year":"2004","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579018_bb0095","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00005373-199101000-00007","article-title":"Early measurement of systemic lipid peroxidation products in the plasma of major blunt trauma patients","volume":"31","author":"Girotti","year":"1991","journal-title":"J. Trauma"},{"issue":"7","key":"10.1016\/j.jneuroim.2026.579018_bb0100","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/brain\/awr128","article-title":"Oxidative damage in multiple sclerosis lesions","volume":"134","author":"Haider","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2026.579018_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102987","article-title":"Mitochondrial dynamics in neurodegenerative diseases: research hotspots and trends from 2005 to 2025","volume":"114","author":"Hu","year":"2026","journal-title":"Ageing Res. Rev."},{"issue":"12","key":"10.1016\/j.jneuroim.2026.579018_bb0110","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.3390\/ijms25126289","article-title":"Oxidative stress markers in multiple sclerosis","volume":"25","author":"Jim\u00e9nez-Jim\u00e9nez","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579018_bb0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12035-015-9648-6","article-title":"Genetic, immune-inflammatory, and oxidative stress biomarkers as predictors for disability and disease progression in multiple sclerosis","volume":"54","author":"Kallaur","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jneuroim.2026.579018_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103959","article-title":"The effect of timing of high-efficacy therapy on processing speed performance in multiple sclerosis","volume":"64","author":"Labiano-Fontcuberta","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579018_bb0125","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbadis.2015.09.018","article-title":"Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions","volume":"1862","author":"Lassmann","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"10","key":"10.1016\/j.jneuroim.2026.579018_bb0130","article-title":"A meta-analysis of oxidative stress markers in depression","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579018_bb0135","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","article-title":"Pathological mechanisms in progressive multiple sclerosis","volume":"14","author":"Mahad","year":"2015","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.jneuroim.2026.579018_bb0140","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/S0021-9258(19)45228-9","article-title":"The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase","volume":"247","author":"Misra","year":"1972","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2026.579018_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1688158","article-title":"Exposome, oxidative stress and inflammation in persons with multiple sclerosis: the EXPOSITION study protocol","volume":"13","author":"Monti","year":"2025","journal-title":"Front. Public Health"},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579018_bb0150","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11011-012-9324-8","article-title":"A neuro-immune model of myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"28","author":"Morris","year":"2013","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.jneuroim.2026.579018_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103432","article-title":"Circulatory antioxidant and oxidative stress markers are in correlation with demographics but not cognitive functions in multiple sclerosis patients","volume":"57","author":"Naseri","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"11","key":"10.1016\/j.jneuroim.2026.579018_bb0160","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1001\/jamaneurol.2015.2332","article-title":"Association between glutamate blockade and fatigue in patients with multiple sclerosis","volume":"72","author":"Nourbakhsh","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2026.579018_bb0165","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.expneurol.2015.11.010","article-title":"Oxidative stress in multiple sclerosis: central and peripheral mode of action","volume":"277","author":"Ohl","year":"2016","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579018_bb0170","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1007\/s12035-016-9860-z","article-title":"Albumin and protein oxidation are predictors that differentiate relapsing-remitting from progressive clinical forms of multiple sclerosis","volume":"54","author":"Oliveira","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jneuroim.2026.579018_bb0175","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jns.2017.07.046","article-title":"Vitamin D deficiency is associated with disability and disease progression in multiple sclerosis patients independently of oxidative and nitrosative stress","volume":"381","author":"Oliveira","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2026.579018_bb0180","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/708659","article-title":"Immunology and oxidative stress in multiple sclerosis: clinical and basic approach","volume":"2013","author":"Ortiz","year":"2013","journal-title":"Clin. Dev. Immunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579018_bb0185","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.autrev.2015.11.005","article-title":"Multiple sclerosis and fatigue: a review on the contribution of inflammation and immune-mediated neurodegeneration","volume":"15","author":"Patejdl","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2026.579018_bb0190","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7191080","article-title":"Inflammation and oxidative stress in multiple sclerosis: consequences for therapy development","volume":"2020","author":"Pegoretti","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.jneuroim.2026.579018_bb0195","series-title":"Handbook of Disease Burdens and Quality of Life Measures","year":"2010"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579018_bb0200","doi-asserted-by":"crossref","first-page":"19630","DOI":"10.1038\/s41598-022-24152-2","article-title":"Ferroptosis inhibition by deferiprone attenuates myelin damage and promotes neuroprotection in demyelinated optic nerve","volume":"12","author":"Rayatpour","year":"2022","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.579018_bb0205","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00008571-199912000-00009","article-title":"Determination of paraoxonase (PON1) status requires more than genotyping","volume":"9","author":"Richter","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jneuroim.2026.579018_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.106122","article-title":"161. Long-term effects of cladribine tablets treatment on cognition, relapses, MRI, and safety outcomes in patients with relapsing multiple sclerosis: 4-year results from the CLARIFY-MS extension study","volume":"92","author":"Selmaj","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.579018_bb0215","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3390\/molecules24081583","article-title":"Oxidative stress: a key modulator in neurodegenerative diseases","volume":"24","author":"Singh","year":"2019","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.jneuroim.2026.579018_bb0220","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000374","article-title":"Lipoic acid in secondary progressive MS: a randomized controlled pilot trial","volume":"4","author":"Spain","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.579018_bb0225","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s10072-020-04807-6","article-title":"The correlation between circulating inflammatory, oxidative stress, and neurotrophic factors level with the cognitive outcomes in multiple sclerosis patients","volume":"42","author":"Talebi","year":"2021","journal-title":"Neurol. Sci."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579018_bb0230","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1468-1331.2008.02090.x","article-title":"Mental fatigue alters the pattern and increases the volume of cerebral activation required for a motor task in multiple sclerosis patients with fatigue","volume":"15","author":"Tartaglia","year":"2008","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579018_bb0235","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2026.579018_bb0240","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/898393","article-title":"Markers of oxidative stress and neuroprogression in depression disorder","volume":"2015","author":"Vav\u00e1kov\u00e1","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"5","key":"10.1016\/j.jneuroim.2026.579018_bb0245","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ki.1996.186","article-title":"Advanced oxidation protein products as a novel marker of oxidative stress in uremia","volume":"49","author":"Witko-Sarsat","year":"1996","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579018_bb0250","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1474-4422(23)00377-0","article-title":"Blood-brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies","volume":"23","author":"Zierfuss","year":"2024","journal-title":"Lancet Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:56:47Z","timestamp":1791316607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572826001670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":50,"alternative-id":["S0165572826001670"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579018","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral redox biomarkers in multiple sclerosis: associations with phenotype, cognition, and fatigue","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"579018"}}